CNO Honours Diversity and Dedication for Nursing Week Français
TORONTO, ON, May 12, 2025 /CNW/ - As the regulator for the province's approximately 200,000 nurses, the College of Nurses of Ontario (CNO) understands the vibrant diversity nurses bring to their roles. That's why we are thanking nurses this Nursing Week with a campaign that shows different ways nurses transform patients' health.
CNO is proud to celebrate Nursing Week, taking place from Monday, May 12 to Sunday, May 18, 2025. This annual event recognizes and celebrates the invaluable contributions of nurses, while fostering visibility and trust within the profession.
"Nurses, we thank you for being true leaders who demonstrate unwavering commitment, champion positive change and dedicate your lives to serving patients," said Silvie Crawford, RN, CNO's Registrar/Executive Director & CEO. "The work you do matters. You enrich lives by bringing your unique experiences to the care you provide. Your care and compassion transform patients' lives."
This year, CNO's Nursing Week campaign celebrates the vibrant diversity within the nursing profession under the central theme, "This is Nursing." Through a series of videos, CNO honours the rich tapestry of lived experiences, varied approaches and meaningful journeys that enrich the nursing profession and support safe patient care.
Throughout Nursing Week, we will share authentic stories and heartfelt messages from nurses, as well as their patients and employers. Our campaign highlights the diverse knowledge, experiences and skills nurses bring to their roles, the diverse practice settings they work in and the different patients they care for.
Whether in acute care, the community, classrooms, palliative care or so many other settings, nurses' contributions are invaluable in shaping health care, driving innovation and advocating for patient-centred care. From rural communities to urban centres and northern regions, nurses are the heart of health care, bringing diversity and expertise to every aspect of their practice.
"Nurses bring rich experiences and unique strengths to our profession," said Nitha Reno, Manager, Interprofessional Practice and Innovation Long-Term Care & Services for Seniors Division at the Regional Municipality of Durham. "We navigate complex challenges every day, and yet, it is nurses' unwavering commitment that brings comfort, dignity and hope to those we serve," said Reno.
"Diversity in nursing is about the many ways we care. Through our identities. Our values. Our practices," said Leonor De Biasio, RN, at Humber College and VHA Home HealthCare in Toronto. "Care extends far beyond hospital walls. Nurses are in homes and families' lives in such meaningful ways."
By sharing personal stories of nursing, CNO underscores the transformative impact of nurses on individuals and communities they serve. "The best part of my job is having a positive impact on the lives of my clients and advocating for them, to ensure that they've received the best care possible," said Samantha McAran, RPN, at The Care Company Home Care Services in Toronto.
Nurses inspire through their dedication, lead with compassion and enrich health care with their unique worldviews and experiences. "Nurses have the opportunity to make a difficult situation easier by providing comfort to clients. One way we can do this is by incorporating a client's culture and beliefs into their care when possible" McAran said.
"As we celebrate Nursing Week, I am deeply honoured to recognize the vibrant diversity and unwavering dedication of nurses across Ontario. Their unique perspectives, compassionate leadership and innovative spirit continue to transform health care and inspire communities," said Crawford. "This week, and every week, let us express our heartfelt gratitude for the extraordinary contributions nurses make in shaping a healthier future for all."
We invite everyone to recognize the incredible work of nurses during Nursing Week 2025. Together, we can honour the profound impact nurses have on shaping health care and enriching lives through their compassion and dedication.
About the College of Nurses of Ontario:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
an hour ago
- Cision Canada
AURORA CANNABIS CHS CLASS ACTION CERTIFIED
TORONTO, June 9, 2025 /CNW/ - Thousands of Canadian cannabis users are hospitalized and diagnosed with Cannabinoid Hyperemesis Syndrome ("CHS") every year. CHS is a dangerous side effect that can develop from the regular use of cannabis products. CHS involves cyclical bouts of severe nausea, vomiting, and abdominal pain, which can persist for days and can occur as often as once every five minutes. In extreme cases, CHS can result in organ failure and even death. On May 14, 2025, the Ontario Superior Court of Justice certified a national class action which alleges that Aurora Cannabis Inc, and Aurora Cannabis Enterprises Inc. negligently failed to warn consumers of the risk of developing CHS posed by the regular use of their cannabis products. This means that the action can now proceed as a class action. No findings of liability have been made against the defendants. The action was commenced by V.T., a Canadian Forces veteran who was prescribed cannabis to treat medical conditions. V.T. purchased medicinal cannabis from the Defendants, and used it as prescribed, until they suffered two extreme bouts of nausea, vomiting and abdominal pain that were so severe V.T. had to be hospitalized. On the second E.R. visit, V.T. was diagnosed as suffering from CHS. The only certain cure for CHS is to stop consuming cannabis, which V.T. did, and is now symptom-free. None of the cannabis products that V.T. consumed contained any warning about CHS, nor is there any warning in the product monograph, or on Aurora's website. The claim alleges that the Defendants knew, or should have known, of the risk of CHS arising from the regular use of their cannabis products, but negligently failed to provide any warning to consumers or prescribing physicians about the risk that they could develop CHS. The class action seeks to recover damages for the Class Members who developed CHS. The class action is brought on behalf of all persons in Canada who purchased a Cannabis Product from Aurora Cannabis Inc. or Aurora Cannabis Enterprises Inc. (which includes MedReleaf) on or after February 1, 2014 to May 14, 2025 (the "Class Period") who were diagnosed or differentially diagnosed with CHS during the Class Period after consuming one or more Cannabis Products. Cannabis Products are the cannabis and/or synthetic cannabinoid resins, pills, lozenges, concentrates, oils, edibles, beverages, vapours, and raw and adulterated plant material cultivated, designed, manufactured, packaged, labeled, distributed, marketed, and/or sold by the Defendants. The allegations contained in the Fresh as Amended Statement of Claim have not been proven in court, and the Defendants deny the Plaintiff's claims. . Sotos Class Actions 55 University Avenue, Suite 600 Toronto, ON M5J 2H7 [email protected] 1-877-294-9747 (toll free) For media inquiries, please contact Margaret Waddell by phone at 416.977.2413 or by email at [email protected].
Cision Canada
7 hours ago
- Cision Canada
Ambassadors Accelerate CarePatrol's AlignedCare™ Program
Beta testing begins for proprietary value-based care model driven by advisor insights OTTAWA, Ontario, June 9, 2025 /CNW/ -- CarePatrol, a leading senior care solutions franchise with more than 200 locations open across 40 states and Canada, is advancing its proprietary AlignedCare™ Value-Based Care (VBC) Certification Program with the selection of its first Ambassador team. The select group of experienced advisors will act as early adopters, leading beta testing and shaping the future for value-based care integration within senior care advisory services. The AlignedCare Program represents a transformative step in how care solutions are guided and recommended. Advisors who complete the certification will be qualified to support families using an evidence-informed model based on outcomes, social determinants of health, and care collaboration. Built on value-based care principles informed by the 8 Dimensions of Wellness, the program enables higher levels of client precision and personalization, while also expanding value-based care partnership networks. Throughout the beta phase, AlignedCare Ambassadors will be applying the model within their current practices and providing critical feedback on assessment tools, strategic workflows, and outcomes tracking. Insights provided and gained during this phase will assist in system-wide implementation. "We're thrilled with the early momentum of the AlignedCare Program and the enthusiasm from our Ambassador team," said Becky Bongiovanni, co-founder and brand president of CarePatrol. "Our advisors are stepping into a leadership role that goes far beyond traditional care advisory. By aligning every recommendation with value-based care principles, we are building a more complete, measurable, and compassionate model for senior care." Each AlignedCare Ambassador plays a vital role in strengthening CarePatrol's mission to strengthen senior care advisory services through professional development, collaboration, and meaningful community impact. This next phase of the initiative builds on CarePatrol's legacy of innovation, using evidence-informed practices to deliver personalized, outcome-focused advisory solutions. A full system-wide rollout of the AlignedCare™ Certification Program is anticipated later this year. About CarePatrol CarePatrol is the nation's largest senior care solutions franchise in the United States. With more than 225 locations sold across 40 states and Canada, local senior advisors provide a no-cost service in helping families find quality, top-rated independent living, assisted living, memory care, long-term care, and home care. Founded in 1993, CarePatrol began franchising in 2009 and is now part of the Best Life Brands family, with private equity backing by The Riverside Company. CarePatrol is proud to have earned the Franchisee Satisfaction Award from Franchise Business Review for 14 years in a row, including its induction into the Hall of Fame in 2024, and has earned placement on the Entrepreneur Franchise 500 list. For more information, visit
Cision Canada
7 hours ago
- Cision Canada
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care Français
TORONTO, June 9, 2025 /CNW/ - Sanofi Canada today announced the appointment of James Guy as Country Lead, Canada and General Manager, Specialty Care. In this role, Guy will lead Sanofi's Canada Country Council, which manages the operations of the company's three business units and functions. Guy will also head the Specialty Care business unit in Canada. Country Lead, Canada and General Manager, Specialty Care "This is an exciting time in Sanofi's history, with the potential for our promising pipeline to deliver several scientific breakthroughs that can improve healthcare around the globe. The company is building on this momentum, leveraging next-gen technology and AI, to turn breakthrough science into reality for patients. I feel privileged to be back home in Canada working with our talented teams; I'm confident that their patient-focused approach will deliver new solutions that will continue to benefit Canadian patients." Guy brings over two decades of pharmaceutical industry experience, including 13 years with Sanofi in global, US, and Canadian leadership roles, most recently as the Immunology Franchise Head in Canada. His prior positions within Sanofi include International Strategic Marketing Director based in the Czech Republic, Respiratory Global Brand Lead based in the US, and Regional Business Director in the US affiliate. A Canadian citizen, Guy holds a in Applied Chemistry & Biology from Toronto Metropolitan University, an in Biomedical Sciences from the University of Bradford (UK), and an MBA from Rutgers University (USA). With over 2,000 employees across the country, Sanofi's operations in Canada include R&D, Commercial, the country's largest biomanufacturing facility, and an AI Centre of Excellence. The company is uniquely positioned to deliver across the full life sciences value chain within Canada. As Country Lead, Guy will chair the Canada Country Council, which includes: About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. In Canada, we employ over 2,000 people and invest 20% of our revenue annually in biopharma research, representing $1.2 billion CAD in R&D over the last decade, creating jobs, business, and opportunity throughout the country. We are the largest biomanufacturing facility in Canada and are on track to deliver over $2 billion in new infrastructure investments by 2028, including two new vaccine manufacturing facilities at our Toronto Campus. For more than 110 years, we have been working in collaborative partnerships with a vast network of healthcare stakeholders and are committed to creating a healthier future in Canada.
